Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Limited impact of Delta variant’s mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population

View ORCID ProfileCarlos A. Sariol, Crisanta Serrano-Collazo, Edwin J. Ortiz, Petraleigh Pantoja, Lorna Cruz, Teresa Arana, Dianne Atehortua, Christina Pabon-Carrero, Ana M. Espino
doi: https://doi.org/10.1101/2021.10.25.21265422
Carlos A. Sariol
aDepartment of Microbiology and Medical Zoology, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
bUnit of Comparative Medicine, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
cDepartment of Internal medicine, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos A. Sariol
  • For correspondence: carlos.sariol1{at}upr.edu
Crisanta Serrano-Collazo
bUnit of Comparative Medicine, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin J. Ortiz
bUnit of Comparative Medicine, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
dPuerto Rico Science, Technology and Research Trust, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petraleigh Pantoja
bUnit of Comparative Medicine, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorna Cruz
aDepartment of Microbiology and Medical Zoology, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
bUnit of Comparative Medicine, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Arana
aDepartment of Microbiology and Medical Zoology, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
bUnit of Comparative Medicine, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dianne Atehortua
dPuerto Rico Science, Technology and Research Trust, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Pabon-Carrero
dPuerto Rico Science, Technology and Research Trust, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana M. Espino
aDepartment of Microbiology and Medical Zoology, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The SARS-CoV-2 pandemic has impacted public health systems all over the world. The Delta variant seems to possess enhanced transmissibility, but no clear evidence suggests it has increased virulence. Our data shows that pre-exposed individuals had similar neutralizing activity against the authentic COVID-19 strain and the Delta and Epsilon variants. After one vaccine dose, the neutralization capacity expands to all tested variants. Healthy vaccinated individuals showed a limited breadth of neutralization. One vaccine dose induced similar neutralizing antibodies against the Delta compared to the authentic strain. However, even after two doses, this capacity only expanded to the Epsilon variant.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The Puerto Rico Science, Technology and Research Trust supported research reported in this work under agreement number 2020-00272 to AME and CAS. Also, the University of Puerto Rico contributed with the UPR-COVID-19 Grant to CAS and AME. This work was also supported by 1U01CA260541-01 to CAS (NCI/NIAID).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Samples used in this study were obtained from adult volunteers (>21 years old) participating in the IRB approved clinical protocol Molecular Basis and Epidemiology of Viral infections circulating in Puerto Rico, Pro0004333. Protocol was submitted to, and ethical approval was given by, Advarra IRB on April 21, 2020. Also this protocol was approved by the IRB at the Medical Sciences Campus, University of Puerto Rico.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Limited impact of Delta variant’s mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Limited impact of Delta variant’s mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population
Carlos A. Sariol, Crisanta Serrano-Collazo, Edwin J. Ortiz, Petraleigh Pantoja, Lorna Cruz, Teresa Arana, Dianne Atehortua, Christina Pabon-Carrero, Ana M. Espino
medRxiv 2021.10.25.21265422; doi: https://doi.org/10.1101/2021.10.25.21265422
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Limited impact of Delta variant’s mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population
Carlos A. Sariol, Crisanta Serrano-Collazo, Edwin J. Ortiz, Petraleigh Pantoja, Lorna Cruz, Teresa Arana, Dianne Atehortua, Christina Pabon-Carrero, Ana M. Espino
medRxiv 2021.10.25.21265422; doi: https://doi.org/10.1101/2021.10.25.21265422

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3314)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13397)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5175)
  • Geriatric Medicine (482)
  • Health Economics (785)
  • Health Informatics (3284)
  • Health Policy (1145)
  • Health Systems and Quality Improvement (1198)
  • Hematology (432)
  • HIV/AIDS (1023)
  • Infectious Diseases (except HIV/AIDS) (14651)
  • Intensive Care and Critical Care Medicine (915)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4950)
  • Nursing (262)
  • Nutrition (734)
  • Obstetrics and Gynecology (888)
  • Occupational and Environmental Health (797)
  • Oncology (2530)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1305)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (558)
  • Psychiatry and Clinical Psychology (4223)
  • Public and Global Health (7525)
  • Radiology and Imaging (1714)
  • Rehabilitation Medicine and Physical Therapy (1019)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)